Filing Details
- Accession Number:
- 0001790300-21-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-17 19:07:03
- Reporting Period:
- 2021-07-22
- Accepted Time:
- 2021-09-17 19:07:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427570 | Reshape Lifesciences Inc. | RSLS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1773309 | P. Barton Bandy | 1001 Calle Amanecer San Clemente CA 92673 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Acquisiton | 2021-07-22 | 960,100 | $0.00 | 960,100 | No | 4 | A | Direct | |
| Common Stock, $0.001 Par Value Per Share | Acquisiton | 2021-07-22 | 225,906 | $0.00 | 1,186,006 | No | 4 | A | Direct | |
| Common Stock, $0.001 Par Value Per Share | Disposition | 2021-09-10 | 294,494 | $2.89 | 891,512 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- These shares will vest and be issued with respect to 480,050 shares on July 22, 2021 and the remaining shares vesting monthly thereafter for 36 months pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
- These shares will vest and be issued monthly over 36 months beginning on July 22, 2021 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
- These shares were sold to cover taxes in connection with the vesting of restricted stock units.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.88 to $2.90, inclusive. The Reporting Person undertakes to provide to ReShape Lifesciences Inc., any security holder of ReShape Lifesciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
Billionaire Hedge Funds
